C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2006
12/06/2006	EP1682570A4 A binding motif and methods of regulating cell function
12/06/2006	EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof
12/06/2006	CN1872872A Peptide synthase gene, peptide synthase and process for producing dipeptide
12/05/2006	US7144902 Prodrugs of thrombin inhibitors
12/05/2006	US7144901 Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
12/05/2006	US7144899 Thrombin inhibitors
12/05/2006	US7144877 Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
12/05/2006	US7144856 A salt of N-dipeptidoyl-O-acylhydroxyamines; suicide inhibitors which deactivate the DP I by the reaction with the nucleophilic active site thiol residue; inhibitors of the cysteine protease dipeptidyl peptidase I; cell degeneration, immune diseases impaired wound healing and metabolic diseases
11/2006
11/30/2006	WO2006128027A1 Functionally active recombinant peptides, methods for producing same and interactions with other peptides
11/30/2006	WO2006126557A1 Compound having photosensitization activity, photoelectrode, and photosensitization-type solar cell
11/30/2006	WO2006126087A2 Angiotensin i-converting enzyme (ace) inhibitors
11/30/2006	WO2006125847A1 Production of and antihypertensive properties of peptides derived from egg white proteins
11/30/2006	US20060270829 G-csf conjugates
11/30/2006	US20060270609 Inhibitors for the soluble epoxide hydrolase
11/30/2006	US20060270042 High-titer retroviral packaging cells
11/30/2006	CA2609812A1 Angiotensin i-converting enzyme (ace) inhibitors
11/30/2006	CA2609811A1 Angiotensin i - converting enzyme (ace) inhibitors
11/30/2006	CA2608522A1 Biomarkers for breast cancer
11/29/2006	EP1725579A1 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/29/2006	EP1725577A1 Antithrombotic compound
11/29/2006	EP1725576A2 Positive modulator of bone morphogenic protein-2
11/29/2006	EP1299724B1 Synthetic peptide for neurological disorders
11/29/2006	EP1218403B1 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
11/29/2006	CN1869235A Method for modifying plant morphology, biochemistry and physiology
11/29/2006	CN1869061A Peptidomimetic protease inhibitors
11/28/2006	US7141680 Such as ((2-(3-guanidino-2-hydroxy-propylcarbamoyl)-1H-indol-5-yl)-amide)
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	US7141594 inhibitors of HIV protease for treating AIDS
11/28/2006	US7141263 Process for producing cinnamaldehyde derivatives, use thereof and the like
11/23/2006	WO2006122910A1 Halogenated quindoline dimers for the treatment of cancer
11/23/2006	WO2006096652A3 Process for preparing macrocyclic compounds
11/23/2006	WO2005086967A3 Therapeutic use of rm1 antigen
11/23/2006	US20060264605 Polypeptides having anti-HIV activity and compositions comprising same
11/23/2006	US20060264604 Anti-HBs monoclonal antibody
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264379 BIR domain binding compounds
11/23/2006	DE102005055946A1 Cyclische Iminopeptid-Derivate Cyclic Iminopeptid derivatives
11/23/2006	DE102005022845A1 Thiobernsteinsäurederivate und deren Verwendung Thiobernsteinsäurederivate and their use
11/23/2006	CA2606785A1 Fibroblast activation protein inhibitor compounds and methods
11/22/2006	EP1724287A1 Hyaluronic acid/methotrexate compound
11/22/2006	EP1723165A1 Identification of n-alkylglycine trimers for induction of apoptosis
11/22/2006	EP1723164A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
11/22/2006	EP1723163A2 Isopeptide gap junction modulators
11/22/2006	EP1723124A1 Propenoyl hydrazides
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1035131B1 Process for the preparation of n2 -(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline
11/22/2006	EP0942925B1 Inhibitors of interleukin-1 beta converting enzyme
11/22/2006	EP0890105B1 Methods related to Alzheimer's disease for diagnosis, manufacture of medicaments and screening of substances and beta-amyloid related peptides
11/22/2006	CN1867580A Compound modified with glycerol derivative
11/22/2006	CN1867579A Novel peptidomimetic NS3-serine protease inhibitors of hepatitis c virus
11/21/2006	US7138493 ATP-binding cassette protein responsible for cytotoxin resistance
11/21/2006	US7138488 Viricides
11/21/2006	US7138486 Insulinotropic hormone derivatives and uses thereof
11/16/2006	WO2006122188A2 Tripeptides as hepatitis c virus inhibitors
11/16/2006	WO2006079934A3 Inhibition of sweat malodour
11/16/2006	US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006	US20060258598 Alpha-keto carbonyl calpain inhibitors
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy
11/16/2006	US20060258571 Antibacterial ester macrocycles
11/16/2006	US20060257980 Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
11/15/2006	EP1722227A2 Epitopes formed by non-covalent association of conjugates
11/15/2006	EP1720898A2 Antihypertensive peptides from casein hydrolysates
11/15/2006	EP1517997A4 Luminogenic protease substrates
11/15/2006	EP1406920B1 Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities
11/15/2006	CN1863506A Methods for preparing oil bodies comprising active ingredients
11/14/2006	US7135549 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization
11/14/2006	US7135462 Hepatitis C virus inhibitors
11/14/2006	US7135457 Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
11/14/2006	US7135453 Reagents and methods for smooth muscle therapies
11/09/2006	WO2006118327A1 Cationic amino acid type lipid
11/09/2006	WO2004094454A3 Hla-a2 tumor associated antigen peptides and compositions
11/09/2006	US20060252958 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril
11/09/2006	US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/09/2006	US20060252130 Method for linking molecular substances
11/09/2006	US20060252109 Peptide conjugates and fluorescence detection methods for intracellular caspase assay
11/09/2006	US20060251649 Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
11/09/2006	DE10361140B4 Verfahren zur Herstellung von dendritischen Trimesinsäuretriamiden, dabei verwendete Diethylentriaminderivate und Verwendung der Diethylentriaminderivate A process for the preparation of dendritic Trimesinsäuretriamiden, Diethylentriaminderivate used therein and using the Diethylentriaminderivate
11/08/2006	EP1718667A2 Heterocyclic self-immolative linkers and conjugates
11/08/2006	EP1718639A2 Caspase inhibitors and uses thereof
11/08/2006	EP1718300A2 Conformationally constrained smac mimetics and the uses thereof
11/08/2006	EP1359934B1 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1860129A Novel peptide ligands of leukocyte integrins
11/08/2006	CN1283659C Truncated glial cell line-derived neurotrophic factor
11/08/2006	CN1283658C Proline ester and preparation containing the same for percutaneous administration
11/08/2006	CN1283657C Novel chromogenic substances and use thereof for the determination of carboxypeptidase activities
11/08/2006	CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006	CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
11/07/2006	US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006	US7132559 Thermal and chemical denaturing resistance; tailored protein cores
11/07/2006	US7132504 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid
11/07/2006	US7132475 Synthesis of preerential block copolymers; provide chemical intermediates, generate polymeric thiol, polymerize second compound which contains episulfide, recover block copolymer
11/07/2006	US7132458 Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132401 Beta-secretase substrates and uses thereof
11/07/2006	US7132392 administering to mammals peptides having angiostatic activity, that inhibit hepatocyte growth factor induced cell migration and binding between intracellular transducers and receptor protein tyrosine kinases; anticarcinogenic agents
11/07/2006	US7132295 Isotopically coded affinity markers 3
11/02/2006	WO2006116535A1 Green tea polyphenol alpha secretase enhancers and methods of use
11/02/2006	WO2006114657A1 Lys-thr dipeptides and their use
11/02/2006	WO2006114478A1 Diagnostic and therapeutic agents

1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 307